NAT-PREGABALIN
Identification of Nat-Pregabalin
| No description |
Google image searchProduct monograph
Active ingredient
pregabalin, 225 MG
DIN: 02494892
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 07-MAY-2020
ATC:
- N02 — ANALGESICS (ATC, ATC/DDD, )
- N02B — OTHER ANALGESICS AND ANTIPYRETICS (ATC, ATC/DDD)
- N02BF — Gabapentinoids (ATC, ATC/DDD)
- N02BF02 — PREGABALIN (ATC/DDD)
Reference brand drug: Lyrica
Pharmaceutical standard: MFR
